Trial Details

Authorised
Basic Information
Clinical ID c2691
Identifier EUCTR2018-001402-28-ES
Trial Title PROTOCOL FOR THE OPTIMIZATION OF THE PREPARATION FOR THE COLONOSCOPY IN PATIENTS WITH INTESTINAL INFLAMMATORY DISEASE
Trial URL Visit Original Page
Study Information
Study Results

No results available

Conditions preparation in patients with inflammatory bowel disease who will undergo an endoscopy;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
Interventions Trade Name: Moviprep Sabor Naranja Pharmaceutical Form: Powder for oral solution INN or Proposed INN: MACROGOL 3350 CAS Number: 25322-68-3 Other descriptive name: MACROGOL 3350 Concentration unit: g gram(s) Concentration type: equal Concentration number: 100- INN or Proposed INN: SODIUM SULFATE ANHYDROUS CAS Number: 7757-82-6 Other descriptive name: SODIUM SULFATE ANHYDROUS Concentration unit: g gram(s) Concentration type: equal Concentration number: 7.500- INN or Proposed INN: SODIUM CHLORIDE Other descriptive name: SODIUM CHLORIDE Concentration unit: g gram(s) Concentration type: equal Concentration number: 2.691- INN or Proposed INN: POTASSIUM CHLORIDE Other descriptive name: POTASSIUM CHLORIDE Concentration unit: g gram(s) Concentration type: equal Concentration number: 1.015- INN or Proposed INN: ASCORBIC ACID Other descriptive name: ASCORBIC ACID Concentration unit: g gram(s) Concentration type: equal Concentration number: 4.700- INN or Proposed INN: SODIUM ASCORBATE CAS Number: 134-03-2 Other descriptive name: SODIUM ASCORBATE Concentration unit: g gram(s) Concentration type: equal Concentration number: 5.900- INN or Proposed INN: SODIUM Other descriptive name: SODIUM Concentration unit: mmol/l millimole(s)/litre Concentration type: equal Concentration number: 181.6- INN or Proposed INN: SULFATE CAS
Participant Information
Sponsor Hospital Universitario La Paz
City -
Country/Region Spain
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE4
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -